Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

miRNA

  • Open Access
    LET-7a and LET-7b as Potential Signatures for Glioma Recurrence, Regardless of WHO Tumor Grade
    SYLVIE WEBER, SASKIA KUHL, ROLAND GOLDBRUNNER and MARCO TIMMER
    Anticancer Research December 2024, 44 (12) 5199-5205; DOI: https://doi.org/10.21873/anticanres.17346
  • You have access
    Analysis of Methylation of Tumor-suppressive miRNAs and KRAS/TP53 Mutations in Pancreatic Juice
    KOUSHIRO OHTSUBO, KUNIO MIYAKE, SHIGEKI SATO, HIROYUKI SAKAGUCHI, KOJI FUKUDA, HIROSHI KOTANI, AKIHIRO NISHIYAMA, SHIGEKI NANJO, KANAME YAMASHITA, SHINJI TAKEUCHI, SEIJI YANO, SAWAKO KURUMA, JUN NAKAHODO, MASATAKA KIKUYAMA and HIROAKI TANIGUCHI
    Anticancer Research December 2024, 44 (12) 5253-5261; DOI: https://doi.org/10.21873/anticanres.17353
  • You have access
    Elucidating the Role of Let-7d-5p and OLR1 in the Progression and Prognosis of Oral Squamous Cell Carcinoma via FAK/P53 Signaling Axis
    CHE-HSUAN LIN, CHIH-CHIU CHIANG, YA-CHI SHIH, SHIAO-LIN TUNG and WEI-CHIEH HUANG
    Anticancer Research June 2024, 44 (6) 2517-2531; DOI: https://doi.org/10.21873/anticanres.17058
  • You have access
    Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma
    YOUNG WHA KOH, JAE-HO HAN, SEOKJIN HAAM and HYUN WOO LEE
    Anticancer Research May 2024, 44 (5) 2081-2089; DOI: https://doi.org/10.21873/anticanres.17012
  • You have access
    Identification of Hub Genes and Upstream Regulatory Factors Based on Cell Adhesion in Triple-negative Breast Cancer by Integrated Bioinformatical Analysis
    YING-HAO HAN, YUAN WANG, SEUNG-JAE LEE, YING-YING MAO, PENG JIANG, HU-NAN SUN, MEI-HUA JIN and TAEHO KWON
    Anticancer Research July 2023, 43 (7) 2951-2964; DOI: https://doi.org/10.21873/anticanres.16466
  • Open Access
    Improved Analysis of Prostate Cancer: VIM3, ATG7 and P53 Form a Complex and Activate miRNA 371a-3p
    ELENA K. NOHL, JASMIN BEHRING, ERSEN KAMERI, BARBARA KÖDITZ, TIM NESTLER, AXEL HEIDENREICH and MELANIE VON BRANDENSTEIN
    Anticancer Research June 2023, 43 (6) 2407-2416; DOI: https://doi.org/10.21873/anticanres.16408
  • You have access
    Evaluation of the M371-Test Under Real-life Conditions for Diagnosis and Follow Up of Testicular Germ Cell Tumors
    STEFAN PYCHA, CAROLINA D’ELIA, CHRISTINE MIAN, CHRISTINE SCHWIENBACHER, ESTHER HANSPETER, MARGHERITA PALERMO, ARMIN PYCHA, HANSJÖRG DANUSER and EMANUELA TRENTI
    Anticancer Research April 2023, 43 (4) 1649-1653; DOI: https://doi.org/10.21873/anticanres.16316
  • You have access
    Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant Melanoma
    MAHYAR SHARIF BAGHERI, JIRI POLIVKA, INKA TRESKOVA, KATERINA HOUFKOVA, TEREZA KNIZKOVA, VLASTIMIL WOZNICA, TOMAS FIKRLE, KRISTYNA PIVOVARCIKOVA, MARTIN SVATON, DATTATRYA SHETTI, RASHMI NEGI and MARTIN PESTA
    Anticancer Research February 2023, 43 (2) 695-706; DOI: https://doi.org/10.21873/anticanres.16208
  • You have access
    Evaluation of the Diagnostic Potential of Circulating MicroRNAs miR-1 and miR-21 in Patients With Ovarian Cancer
    DAMIAN J. RALSER, MATEJA CONDIC, EVA EGGER, DOMINIQUE KOENSGEN, ALEXANDER MUSTEA and MATTHIAS B. STOPE
    Anticancer Research December 2022, 42 (12) 5839-5845; DOI: https://doi.org/10.21873/anticanres.16092
  • Open Access
    Cell Dissociation Enzymes Affect Annexin V/Flow-Cytometric Apoptotic Assay Outcomes After miRNA-based Transient Transfection
    CHRISTINA M. GOBIN, JAMES N. MENEFEE, CHAYIL C. LATTIMORE, ANDRIA DOTY and KRISTIANNA M. FREDENBURG
    Anticancer Research June 2022, 42 (6) 2819-2825; DOI: https://doi.org/10.21873/anticanres.15763

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire